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Althoughsenescenceisadeﬁningpropertyof euploidmammaliancells,itsphysiologicbasisremainsobscure.Previously,cellkinetics
properties of normal tissue cells have not been considered in models for senescence. We now provide evidence that senescence is in
fact the natural consequence of normal in vivo somatic stem cell kinetics extended in culture. This concept of senescence is based
on our discovery that cells engineered to conditionally express the well-recognized tumor suppressor protein and senescence factor,
p53,exhibitasymmetriccellkinetics.In vivo,asymmetriccellkineticsareessentialformaintenanceof somaticstemcells;exvivo,the
same cell kinetics yield senescence as a simple kinetic endpoint. This new“asymmetric cell kinetics model”for senescence suggests
novel strategies for the isolation and propagation of somatic tissue stem cells in culture.
INTRODUCTION
Cellular senescence is a deﬁning property of euploid cells
in culture [1, 2]. Cultures derived from cells explanted from
tissues of a variety of animal species exhibit a ﬁnite number
ofpopulationdoublingsbeforeundergoinganirreversiblear-
rest of cell replication. Several genes have been implicated as
effectorsof senescenceinculture.Theseincludegeneticcom-
ponents of the Rb and p53 growth regulation pathways [3–8]
and genes encoding components of telomerase [9–11]. The
p53 and Rb pathways appear to effect senescence proper, be-
ingrequiredfortheinitialcessationof growthbyprimarycell
cultures [3, 8, 12–14]. In contrast, the ability of telomerase
to extend culture life span is limited to cells that have ﬁrst
escaped senescence [8,12–14].
It has been proposed that the requirement for p53 func-
tion in senescence reﬂects a p53-dependent checkpoint ar-
rest in response to the accumulation of eroded chromosome
ends due to inadequate telomerase activity in explanted so-
matic cells [15, 16]. This idea is now in conﬂict with recent
demonstrationsthatthep53andtelomeraserequirementsfor
senescenceandimmortalization,respectively,areneithersyn-
onymous nor contemporaneous [8,12–14,17]. In this paper,
weformulateanalternativeexplanationfortheimportanceof
p53functionincellularsenescence.Thisexplanationisbased
on our discovery that immortal cells reconstituted with nor-
malp53functionexhibitasymmetriccellkinetics(hereinand
[18–20]).
During asymmetric kinetics, cell divisions yield one
daughter cell that is a long-lived dividing cell like its par-
ent cell. The other daughter is the progenitor of a cell lineage
whose constituents mature into differentiated cells that un-
dergo terminal cell cycle arrest.When cycling,the cells in this
lineage are called transit cells; in their mature arrested state
they are called terminal cells [21,22]. Asymmetric cell kinet-
ics are essential for the function of somatic tissue stem cells.
Itallowsthemtomaintainarelativeconstantfractionintheir
respective tissue and preserve long-term proliferative poten-
tial while simultaneously functioning to renew differentiated
tissue cells [23,24].
Based on the recognition that p53-dependent asymmet-
ric cell kinetics pose an important barrier to the long-term
propagation of primary cells in culture, we present a new
“asymmetric cell kinetics model” for senescence. The new
model accounts for cellular senescence in terms of natural
tissue cell kinetics that continue in culture. Because of its ba-
sis in fundamental principles of somatic stem cell function,
the model suggests speciﬁc strategies to achieve two elusive
goals in stem cell research, identiﬁcation and in vitro propa-
gationofsomaticstemcells.Thereisagreatneedformethods
to enumerate somatic stem cells in vivo and expand them as
pure populations in vitro for applications in medical science,
cancer research, gene therapy, and tissue engineering. The
presented asymmetric cell kinetics model for cellular senes-
cence provides the conceptual basis for the development of
such methods.1:1 (2001)Cellular senescence and ex vivo asymmetric cell kinetics 29
MATERIALSAND METHODS
Cellculture
Temperature-dependent [25] and Zn-dependent [26]
p53-inducible cells were maintained as previously described.
WI-38humanﬁbroblastsweresuppliedbytheAmericanType
Culture Collection. Early passage MEFs from p53 “knock-
out” (ko)mice and wild-type littermates were kindly pro-
vide by L. Donehower (Baylor College of Medicine, Hous-
ton, TX; 27). WI-38 cells and MEFs were maintained in
Dulbecco’s modiﬁed Eagle’s medium (Gibco-BRL)supple-
mented with 10% fetal bovine serum (JRH Biosciences,
Lenexa, KS).
Populationgrowthanalyses
Population doubling times were determined by pub-
lished procedures [18, 19, 26, 27]. Fd values were calcu-
lated from population growth data as previously described
[19].
Time-lapseanalyses
Cells were plated at a density of 104 per 25cm2 culture
ﬂask in 5ml normal growth medium. After approximately
20hours of culture, the culture medium was replaced with
either fresh normal medium (WI-38 and MEFs)or fresh
medium containing 65µM ZnCl2 (p53-inducible cells and
p53-nullcontrolcells)thathadbeenequilibratedovernightin
a37 ◦C-5% CO2 incubator.Atthiscelldensity,65µM ZnCl2 is
sufﬁcient to induce p53-dependent growth suppression [26].
After medium replacement, the ﬂasks were returned to a
37◦C-5% CO2 incubator for 30minutes. Thereafter, culture
ﬂasks were sealed with paraﬁlm and analyzed by time-lapse
cinematography or time-lapse digital imaging microscopy.
Time-lapse cinematography was performed in a 37◦C
warm room with an Olympus IMT-2 inverted light micro-
scope integrated with a Bolex 16mm camera and Olympus
auto-control exposure and frame units. Films were analyzed
using an Athena time-lapse movie projector (Carson, CA).
Time-lapse digital imaging microscopy was performed
using a Quantix cooled CCD camera that was 3× binned
(from 1317 × 1035 to 439 × 345pixels). A Nikon TE300
invertedphase-contrastmicroscopeequippedwithatemper-
ature controlled stage incubator (accurate within 0.1◦C)was
used with sealed ﬂasks. A 4× phase objective with an NA of
0.13wasusedtogiveascaleof 5.1×5.1micronsperpixel.Im-
ageswereacquiredbyISEE(Inovision)imageacquisitionand
analysis software. Stored images were analyzed as animation
within ISEE.
For both methods of time-lapse analysis, image collect-
ing was begun 0.5–1.5hours after ﬂasks were sealed with
paraﬁlm. A single 4× magniﬁcation ﬁeld of cells was pho-
tographed for 80–166hours (average 103 ± 31hours)at a
time-lapse speed of one frame per 3minutes. At the start of
analyses,photographicﬁeldscontained16to43cells(average
25 ± 8.7).
RESULTS AND DISCUSSION
p53-dependentgrowthregulation
issensitivetocelldensity
Weusedaninducibleexpressionstrategytoinvestigatethe
function of p53 in cellular senescence. Immortal murine cell
linesweregeneticallyengineeredtoexpresswild-typemurine
p53 protein conditionally. The prototype lines were derived
from C127 mammary epithelial cells by stable transfection
with a gene expression system activated by reduced tempera-
ture.Whengrownat37◦C,theirroutineculturetemperature,
thesecellsexpresslowlevelsof endogenouswild-typep53.In
a previous report, we showed by immunoprecipitation anal-
yses that culturing at 32.5◦C induces a 2- to 3-fold increase
inp53expression[25].Asecondgenerationof p53-inducible
cell lines was derived by reconstituting spontaneously im-
mortalized p53-null murine embryonic ﬁbroblasts with a
wild-type murine p53 cDNA controlled by a modiﬁed hu-
man metallothionein promoter. We have reported immuno-
precipitation studies which show that, by increasing the Zn
concentration, the p53 protein level of these cells can be in-
creased in a graded fashion from undetectable to near nor-
mal basal levels [26, 27]. For both types of conditional p53-
expressing cells, control lines were derived with expression
plasmids deleted for p53 coding sequences [25–27].
Both types of p53-inducible cells exhibit a decrease in
growth rate under conditions of p53 induction [25–27]. Un-
der the same conditions of temperature and Zn concentra-
tion, no signiﬁcant growth effects occur for control cells.
However, we noted that characteristically this difference in
the growth between control and p53-inducible cells did not
occurathighcelldensity(Figure1).Thepopulationdoubling
time (PDT)of control and p53-induced cells is in fact quite
similar until cell density falls below about 5 × 104 cells per
25cm2. Below this density, p53-speciﬁc growth suppression
is manifest. The PDT of p53-induced cells increases 3-fold
over a 4-fold range of decreased cell density (Figure 1,closed
symbols).Overthesamerange,thePDTof controlcells(Fig-
ure 1, open symbols)is essentially constant. This difference
increases further at colony formation densities. At a density
of 100cells per 25cm2, p53-inducible cells form colonies at
20 to 30 percent the efﬁciency of control cells [25, 26]. The
ability of high cell density to prevent p53-dependent growth
suppressionisovercomebyincreasedlevelsofp53expression.
This can be seen for Zn-dependent cultures initiated at the
high cell density of 1 × 105 cells per 25cm2. Whereas 60µM
Zn does not induce p53-dependent cell cycle arrest, 75µM
Zn,whichinducesahigherlevelof p53protein,doesso([26];
see also Figure 2D).
Sensitivity to low cell density is a well-described charac-
teristic property of presenescent cultures of primary cells of
both murine and human origin [1, 28]. Earlier studies with
murine embryo ﬁbroblasts derived from transgenic p53 gene
knockoutmicesuggestedthatthispropertymightdependon
wild-type p53 expression [29]. Thus, the results of the cell
densitystudiessuggestedtousthatcellsengineeredtorestore30 Lakshmi Rambhatla et al. 1:1 (2001)
wild-type p53 function might regain density-dependent cell
kinetics mechanisms found in normal tissue cells.
p53inducesdensity-dependentlinear
populationgrowthkinetics
Both temperature-dependent [18, 19, 25] and Zn-
dependent p53-inducible cells (Figure 2A, closed circles)ex-
hibit linear population growth kinetics under conditions of
p53 expression. We have shown previously that nonexpo-
nential population growth by cultured cells can be due to
the production of daughter cells that undergo a viable arrest
at a constant rate [19]. To evaluate the effect of cell den-
sity on cell kinetics, Fd, the fraction of new daughter cells
that divide, was determined for control and p53-inducible
cell cultures initiated at different cell densities (Figure 2B
and C).
T h em e t h o do fFd determination has been described in
[19]. Theoretical Fd values range from 0.0 to 1.0. Fd values
greater than 0.5 indicate exponential kinetics. A value of 1.0
corresponds to ideal exponential kinetics in which all daugh-
ter cells divide with a cell cycle time (generation time, GT)
that equals the population doubling time (PDT). Values less
than 0.5 indicate a majority of terminal divisions that re-
sult in two nondividing cells. Since cell death and cell loss
have been shown insigniﬁcant in these p53-expressing cell
cultures [18, 25, 26], an Fd value near the ideal of 0.5 can
indicate one of two distinct cell kinetics programs [22]. It
may indicate that dividing cells and nondividing cells occur
randomly at equal frequency;or that every division produces
one dividing cell and one cell that produces a terminal non-
dividing cell lineage.
We have shown previously that the linear growth ki-
netics of temperature-dependent p53-induced mammary
epithelial cells are due to the latter cell kinetics pro-
gram [18, 19]. For these cells, the increase in population
doubling time at low cell density reﬂects a p53-dependent
switch to asymmetric cell kinetics. Consistent with this
conclusion, the Fd for temperature-dependent p53-induced
cells approaches 0.5 as cell density decreases (Figure 2C,
closed circles). Zn-dependent p53-expressing embryonic ﬁ-
broblasts yield a similar extrapolation of Fd as cell den-
sity decreases (Figure 2C, open circles). Control cells main-
tain an Fd near 1.0 at all tested cell densities (Figure 2B),
consistent with their density-independent exponential cell
kinetics.
The value of Fd depends on the level of p53 expression.
p53 expression in the Zn-dependent ﬁbroblasts increases to a
maximumasZnconcentrationisraisedfrom60µMto90µM
[26]. As shown in Figure 2D (open circles), at the maximum
cell density used in growth experiments, Fd decreases to 0.5
as the Zn concentration is increased from 60µMt o9 0µM.
In a previous report, we provided evidence that individual
cell lineages exhibit either exponential kinetics or asymmet-
rickinetics,butnotmixedpatterns[18].Therefore, Fd values
between 1.0 and 0.5 indicate that whereas some cells initiate
asymmetric kinetics, others continue to divide with expo-
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Figure 1: Reconstitution of normal p53 function restores density-
dependentgrowthtoimmortalcelllines.Populationdoublingtimes
(PDT)were determined from growth curve analyses, performed
at the indicated initial cell densities, for temperature-dependent
(closed circles, lines 1h-3 and 1n-3; 25)and Zn-dependent p53-
inducible cells (closed squares, lines Ind-5 and Ind-8; 26)and their
respective control cells (open circles, lines 1g-1 and 1m-5, 25; open
squares, lines Con-2 and Con-3, 26)grown under p53-inducing
conditions (32.5◦C and 60µM Zn, respectively). Growth curves for
temperature-dependent cells were performed in triplicate; growth
curves for Zn-dependent cells were performed in duplicate or trip-
licate.
nential kinetics. Cell density and p53 expression appear to
be interdependent determinants of the probability that a cell
will adopt asymmetric cell kinetics.
p53isageneticdeterminantofasymmetriccell
kineticsinculturedﬁbroblasts
Time-lapse cinematography and digital imaging
microscopy were used to evaluate p53-dependent cell
kinetics in several different types of ﬁbroblasts. Division
lineages were determined for the p53-inducible murine
embryonic ﬁbroblasts; presenescent murine embryonic
ﬁbroblasts from wild-type mice (wtMEFs)or mice with
a homozygous disruption of the p53 gene (p53koMEFs;
27); and presenescent WI-38 human diploid ﬁbroblasts.
Examples of division lineages for cells expressing wild-type
p53 are diagrammed in Figure 3.
An intriguing cell kinetics feature is evident from the lin-
eageanalyses.Whensymmetricdivisionsoccur(i.e.,divisions
producingtwodividingdaughters),oneofthedaughterstypi-
callyundergoesaterminaldivision(Figure3CandD).Target
gene expression analyses indicate that p53 is active in gene
regulation 2 to 5hours after induction (Y. Liu and J. L. Sher-
ley, submitted), well before the symmetric divisions occur.
This pattern is also observed in the pedigrees of WI-38 cells,
which express wild-type p53 constitutively (Figure 4E and
F). Therefore,it seems unlikely that sub-optimal p53 expres-
sion is responsible. In addition, symmetric divisions of this
type have been observed at later times in lineages as well.1:1 (2001)Cellular senescence and ex vivo asymmetric cell kinetics 31
0                    48                   96                  144 
0
2.5
5
7.5
10
Hours after p53 induction
C
e
l
l
 
n
u
m
b
e
r
 
 
×
1
0
A
r  = 1.0 2
r  = 0.98 2
0 25 50 75 100
0
0.5
1
1.5
2
D
F
d
[Zn] (   M)
1
0.5
0
0 0.4 0.8 1.2 1.6
Cell density (10  cells/25 cm  /5ml)
C
5 2
r  = 0.86; 2 p < 0.025
r  = 0.946;    2 p <  0.03
2
1.5
1
0.5
0
B
y = 1.000
F
d
Cell density (10  cells/25 cm  /5ml) 52
0 0.4 0.8 1.2 1.6   
F
d
-
5
µ
Figure 2: Density-dependent p53 growth regulation reﬂects induction of linear population growth kinetics. (A), Linear growth by p53-
expressing ﬁbroblasts. Growth data for [19] as a function of the initial cell density of temperature-dependent (closed circles)and Zn-
dependent times in Figure 1. (B), Control cells. (C), p53-inducible cells. (D), Response of linear kinetics to p53 level induced by increasing
Zn concentration [26]. The initial cell density ranged from 0.44 to 1.1 × 105 cells/25cm2/5ml. Two to six independent bars indicate the
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Figure 3: Division lineages for p53-expressing ﬁbroblasts. Shown are examples of characteristic asymmetric cell kinetics lineages observed
in time-lapse analyses of p53-inducible cells (line Ind-8; 26)grown under inducing conditions (A–D)and presenescent human and murine
embryonic ﬁbroblast cell strains grown under routine culture conditions. (E) and (F), WI-38 cells at passage 18 and 26, respectively; (G),
wtMEFs at passage 6. Lineages are uneven at end because cell bodies do not indicate passage of time. “Fate uncertain” indicates that a cell
either migrated from the ﬁeld of view or was not observed for sufﬁcient time to assign its division state with conﬁdence.
These occasional symmetric divisions in otherwise simple
asymmetric lineages may indicate variability in transit cell
maturation mechanisms. Whereas, the predominant transit
celldivisionnumber(TDN)forp53-induced“transitcells”in
culture is zero (i.e.,terminal arrest without division),at a low
frequency,transitcellsmaymaturetoaTDNof1(i.e.,asingle
division followed by terminal arrest of both daughters).
From the division lineages, we quantiﬁed the contribu-
tionof differentdivisionsymmetriestothepopulationkinet-
ics of cells with different levels of p53 expression. We deﬁne
three cell division symmetries: (1)terminal, both daughters
are nondividing cells; (2)symmetric, both daughters divide;
and(3)asymmetric,onedaughterdivides,theotherdoesnot
(see Table 1A). Asymmetric divisions are rare (9%) in con-
trol cell cultures that have exponential population kinetics
(i.e., p53-null control cells grown under p53-inducing con-
ditions). In contrast, under conditions for asymmetric cell
kinetics, they are 5 times more frequent than either termi-
nal or symmetric divisions. This frequency is 2.5-fold greater
than the frequency expected if daughter cells divided ran-
domly with 50 percent efﬁciency. It is important to factor
intothisevaluationthat,asnotedabove,symmetricdivisions
observed under conditions of p53 expression characteristi-
cally yield transit cells with a TDN = 1. Therefore, divisions
by p53-expressing cells are effectively all asymmetric.
Although mortal cell strains do exhibit asymmetric divi-
sions,theyarerarecomparedtoterminaldivisionsandtermi-
nal cells (i.e.,cells which do not divide at any time during the
periodof examination).Ninety-twopercent(n = 38)and63
percent (n = 27)of wtMEFs and WI-38 cells, respectively,
were terminal cells. These nondividing cells were detected in
earlier colony formation analyses [18]; and their contribu-
tion to the senescent growth kinetics of mortal cell strains
was predicted in earlier mathematical modeling studies [19].
Asymmetric divisions have not been observed in p53koMEF
cultures. Ninety-two percent of observed divisions in these
cultures were symmetric. This ﬁnding is consistent with the
observation that cells from both embryonic and adult tis-
sues of p53ko mice are immortal in culture from the time of
explant [29, 30].
The division lineage data provided an evaluation of three
important cell kinetics parameters (see Table 1B). These are
PDT, GT, and IDT, the interdivision time. PDT was calcu-
lated under the assumption of exponential growth [19] with
cell count data from monitored cultures and nonmonitored
cultures grown in parallel. GT was determined from the time
elapsed before new daughter cells divided. GT was very sim-
ilar for all cell types. Only p53koMEFs showed a statistically
signiﬁcant difference in GT (versus wtMEFs; p<0.05). The
GTofp53-nullcellswasequivalenttotheirPDT.IDT,thetime
interval between the division of two daughter cells, for p53-
nullcellswasshortcomparedtotheirGT.Thesetworelation-
shipsdeﬁnesymmetriccellkineticsthatproduceexponential
population kinetics. In contrast, despite having comparable
GTs,p53-expressing cells had PDTs that were greater than or
equal to 3-fold longer than their GTs. In fact, during the pe-
riod of analysis, no increase in population size was detected
for mortal cell strains that expressed p53. In earlier studies,1:1 (2001)Cellular senescence and ex vivo asymmetric cell kinetics 33
Table 1: Division symmetry analyses of p53-expressing and p53-null ﬁbroblasts.
A. Division symmetry analysis.
Symmetry Con-3 Ind-8 p53koMEF wtMEF WI-38
(n = 23)( n = 52)( n = 12)( n = 5)( n = 15)
Terminal 17% 15% 8% 40% 80%
Asymmetric 9% 72% 0% 40% 13%
Symmetric 74% 13% 92% 20% 7%
B. Cell kinetics analysis.
Parameter
Con-3 Ind-8 p53koMEF wtMEF WI-38
[Mean hours ISD (h)]
PDT 29 99 17 nid nid
GT 29 ± 8 (37) 34 ± 14 (40) 17 ± 8(36) 30 ± 12 (4) 23 ± 5 (8)
IDT 3 ± 4 (19) ≥ 23 ± 22 (22)* 6 ± 9(14) ≥ 15 ± 14 (3) ≥ 14 ± 16 (5)*
The indicated cells were examined by time-lapse cinematography or digital imaging microscopy: Control p53-null, Con-3 cells, and p53-
inducible,Ind-8cells,grownunderp53-inducingconditions(65µMZnCl2;26);presenescentmurineembryoﬁbroblastsfromeitherwild-type
mice(wtMEF;passage6;27)ormicewithahomozygousdisruptionof thep53gene(p53koMEF;passage12;27);presenescenthumanWI-38
diploid ﬁbroblasts (Data from passage 18 and 26 cultures,which did not differ signiﬁcantly,were combined.)All cells were plated at an initial
density of 1×104 cells per 25cm2 per 5ml medium. (A)Individual divisions within pedigrees were classiﬁed as described in text. n,number
of divisions classiﬁed. (B)Data from pedigree analyses were used to estimate three cell kinetics parameters. PDT, population doubling time.
GT, generation time. IDT, “interdivision time” = GT of second daughter cell to divide-GT of ﬁrst daughter cell to divide. Calculation of
IDT requires that at least one of two new daughter cells divide during the examination period. *In some cases, it was necessary to use the
examination times of second daughter cells,that did not divide during the period of observation,to estimate a minimum value for IDT. nid,
no increase in cell number detected. n, number of cells (for GT)or daughter pairs (for IDT)evaluated.
the PDTs of presenescent WI-38 cells and mortal human in-
testinalepitheliumcellswereshowntobe10-foldgreaterthan
their respective GTs [18,19]. This is not surprising,given the
large fraction of terminal cells in these cultures. Importantly,
the minimum estimate for the IDT of p53-expressing model
cells (see * in Table 1B)was signiﬁcantly longer than that of
p53-null cells (p<0.001). Fewer divisions have been evalu-
ated for p53-expressing mortal strains, but the data indicate
a longer IDT for these cells as well.
Anasymmetriccellkineticsmodelforcellular
senescence
Severalobservationsimplicatep53asanimportantsenes-
cence determinant. p53 protein expression [32] and tran-
scriptional regulation activity [33, 34] are elevated in senes-
centcells;andp53genemutationisfrequentlyassociatedwith
spontaneous immortalization of cells in culture [4, 35, 36].
Several diverse proteins that inactivate wild-type p53 also
immortalize primary cells in culture [3, 37]. Expression of
p21waf1, the p53-induced cyclin kinase inhibitor, has been
implicated as an important senescence determinant. Trans-
genic knockout of the p21waf1 gene is reported to extend
the life span of mortal cell strains in culture [6]. More re-
cently, it has been shown that p53-null immortal tumor cell
lines undergo senescence when wild-type p53 function is re-
stored [38].
Previously, we have shown that near-physiologic expres-
sion of the wild-type p53 protein can induce stem cell-like
asymmetric kinetics in immortal epithelial cell lines [18,19].
In this paper, we extend this seminal ﬁnding to characteri-
zation of asymmetric cell kinetics restored to immortal p53-
null ﬁbroblasts. Recognition of this cellular property of p53
brings a new view to the signiﬁcance of p53 mutations in
human cancers [18,20] and explains its importance in cellu-
lar senescence. We now formulate these new ideas into a cell
kinetics model for senescence in culture (Figure 4).
Many features of tissue cell maturation and differentia-
tion are lost in culture. These processes which occur in the
transit cell compartment [22] may require complex soluble
tissue factor mixtures, extracellular matrix interactions, and
cell-cell interactions that are disrupted or lost in culture. A
critical feature of transit cell maturation in vivo is limited ex-
ponential division. However, the nature of the interactions
among transit cell division, maturation, and differentiation
are poorly understood. These three properties of transit cells
certainly differ from tissue to tissue, and their integration
is likely to differ as well. Such differences may account for
idiosyncratic features of the initial growth kinetics of cell
cultures derived from tissues of different type, different de-
velopmental stage, or different species. Our studies (herein;
[18, 19]; and unpublished data)indicate that, despite the
disruption and loss of in vivo transit cell programs, cells of34 Lakshmi Rambhatla et al. 1:1 (2001)
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Figure 4: Asymmetric cell kinetics model for cellular senescence.
Top,somatictissuestemcell(bold-linedcircles)turnoverunit(TU).
In vivo therearethreestemcellkineticsstates:highlyregulatedsym-
metric kinetics that produce two stem cells (bracketed); dormancy
(stippled circle); and asymmetric cell kinetics, the most populated
stem cell kinetic state in most tissues [21–24]. TDN, the number
of transit cell generations before terminal arrest (closed circles),
varies in different tissues from 0.0 to n. 2TDN = 0.5× number of
transit cells in the TU [24]. Bottom, the ex vivo continuation of in
vivo asymmetric cell kinetics results in cellular senescence. Because
symmetric stem divisions are rare and possibly proapoptotic [31],
asymmetric TU kinetics predominate in culture. The dilution of
asymmetric stem cells by accumulating nondividing terminal cells
is responsible for the observed decline in population doubling rate.
Loss of p53 function in cell culture prevents senescence by allowing
asymmetric stem cells to divide symmetrically; resulting in the ex-
ponentialdivisionthatcharacterizesimmortalization.Insupportof
this model,reconstitution of normal p53 function in immortal cells
restores asymmetric cell kinetics and senescence. PDL, cumulative
population doublings.
diverse tissue origin maintain a rudimentary asymmetric cell
kinetics program in culture.
Inadultsomatictissuesof vertebrates,long-livedsomatic
stem cells, which are responsible for tissue renewal, divide
with asymmetric cell kinetics ([21–23]; see Figure 4, top).
Whether asymmetric stem kinetics result from a stochas-
tic differentiation mechanism that applies to pools of stem
cells or deterministic cellular programs in individual stem
cells continues as a subject of much debate [22]. In the for-
mer model, stem cells divide to produce either two stem cell
daughters or two differentiating daughters. The latter model
is distinguished by individual stem cells that produce both a
stem cell daughter and a differentiating daughter cell from a
singledivision.Ourclonalanalyses[19]andtime-lapsestud-
ies(herein)demonstratethatindividualmammaliancellscan
divide to produce daughters that are asymmetric for cell ki-
netics properties.
Although asymmetric cell kinetics are an essential prop-
erty of somatic stem cells, these cells have a rich cell kinetics
repertoire (see Figure 4, top). They can undergo highly reg-
ulated symmetric expansions in developing adult tissues and
during wound repair. Some stem cells may also lie dormant
for long periods before initiating division in response to spe-
ciﬁc developmental cues, as in reproductive tissues like the
breast. However, the predominant kinetic state of somatic
stem cells in vivo is an asymmetric division program [21–
23]. After each asymmetric stem cell division, one daughter
cell divides with the same kinetics as its stem cell parent, but
the other daughter gives rise to a terminal differentiating lin-
eage. The second daughter may differentiate immediately; or
depending on the tissue, it may undergo a ﬁnite number of
successive symmetric divisions to give rise to a larger pool
of differentiating transit cells [22]. Transit cell divisions ulti-
matelyresultinmature,differentiated,nondividingcells.The
tissuecellrenewalunitcomposedof anasymmetricstemcell,
transitcells,andmaturenondividingcellsiscalledaturnover
unit(TU;24).ATUproducesaﬁxednumberof nondividing
differentiatedtissuecellsperstemcelldivision.Thisregulated
productionof constituentcellsallowsvertebratestocontinu-
ally renew adult tissues while maintaining relatively constant
tissue cell mass [23].
Tissue explants are in effect preparations of disrupted
tissue TUs. Therefore, primary cell cultures initially divide
quite actively due to the division of asymmetric stem cells
and symmetric transit cells. The initial cultures will also con-
tain maturing nondividing cells.With continued passage,the
greateraccumulationof maturenondividingcellswillleadto
dilution of dividing cell types, producing an apparent cessa-
tionof growth(Figure4,bottom).Suchdilutionof stemcells
doesnotoccurinvivo,becausenondividingterminalcellsare
preferentially removed from tissues at rates that match their
production. The cessation of growth in culture will develop
gradually and end with an exponential increase in popula-
tion doubling time that reﬂects dilution of TUs with linear
accumulation kinetics. The exponential increase in PDT in
senescing cultures has been described previously [39].
The presented asymmetric cell kinetics model leads to
three predictions regarding aging and cancer. First, immor-1:1 (2001)Cellular senescence and ex vivo asymmetric cell kinetics 35
talization, the process by which rare cells in culture escape
senescence,mustbeduetoprocessesthatinactivatetheasym-
metric division program of explanted TUs. Second, cancer, a
disease characterized by disruption of TU asymmetric kinet-
ics [23, 24], will be promoted by mutations in genes that
control asymmetric cell kinetics. Third, the association be-
tweencellularsenescenceandagingispredictedtoreﬂectloss
in the number and/or function of somatic tissue TUs with
increasing age. In this paper, we have shown that the ﬁrst
two predictions are realized by the demonstration that the
p53 tumor suppressor gene, a well-known genetic factor for
senescence and cancer, is a regulator of asymmetric cell ki-
netics (see Figure 4, bottom). The presented studies pave the
way for evaluations of the ﬁnal prediction.
Futureapplicationsinstemcellresearch
The model cells and cell kinetics principles described in
this paper have potential for application to several areas of
biomedicine, including stem cell research, gene therapy, and
cancerdrugdiscovery.Somaticstemcellsaretheidealdelivery
vessel for therapeutic genes [40–43]. However, the physical
identiﬁcation of somatic stem cells and their propagation in
culture has not been accomplished [21, 22, 40–43]. To the
extent that asymmetric cell kinetics are unique to somatic
stem cells, gene-proﬁle investigations with the model cells
may yield speciﬁc markers for stem cells.
The asymmetric cell kinetics model of senescence pre-
dicts that one obligate barrier to the propagation of somatic
stem cells in culture will be their inherent asymmetric cell
kinetics.As such,an essential requirement for long-term cul-
ture of somatic stem cells will be the ability to induce them
to proliferate with sustained exponential kinetics. Here, we
show that cell density may be an important factor that in-
creases the frequency of symmetric stem cell divisions. The
cell density required for this effect is less than 1/10 of the
density of cells in conﬂuent monolayers. Therefore,in the ef-
fective range of cell density,there is a signiﬁcant opportunity
for stem cell expansion.
The mechanism by which increased cell density sup-
pressesasymmetriccellkineticsisnotyetknown.However,it
seems unlikely that cell cycle regulatory proteins like p27Kip1
will be involved, because p27Kip1 appears to be required for
cell cycle arrest when exponentially dividing cells reach con-
ﬂuent cell densities [44]. We speculate that the cell density
effect may have an important in vivo correlate. In many tis-
sues,stemcellsarecompartmentalizedinawaythatphysically
andchemicallyinsulatesthemfromotherstemcells[23].Un-
der conditions of tissue damage, these barriers are breached,
allowing for the possibility that stem cells then stimulate the
symmetric expansion of other stem cells by paracrine mech-
anisms. Such a mechanism would promote tissue repair. In
vitro, a similar paracrine mechanism might be responsible
for the switch from asymmetric to exponential cell kinetics
observed at increased cell densities.
Our earlier studies predict that agents that modulate p53
functionmayalsohavetheabilitytopromotestemcellpropa-
gation in culture.We have shown that purine nucleotide pre-
cursors, that overcome p53-induced inhibition of guanine
ribonucleotide biosynthesis, prevent p53-dependent asym-
metric cell kinetics [18, 25, 26]. Given the range of tissues in
which p53 appears to function, these compounds may prove
effectiveforinvitrocultureof stemcellsfromdiversesomatic
tissues. They may also have direct application to age-related
tissue deﬁcits as well. Conversely, compounds that interfere
with the growth of the model cells when they divide with
symmetric kinetics,but not when they divide with asymmet-
ric kinetics, hold promise as particularly selective anticancer
agents [45].
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